Positron emission tomography with 18F-fluorodeoxyglucose of uterine sarcoma:: A comparison with magnetic resonance imaging and power Doppler imaging

被引:98
作者
Umesaki, N
Tanaka, T
Miyama, M
Kawamura, N
Ogita, S
Kawabe, J
Okamura, T
Koyama, K
Ochi, H
机构
[1] Wakayama Med Coll, Dept Obstet & Gynecol, Wakayama 6400012, Japan
[2] Osaka City Univ, Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan
[3] Osaka City Univ, Sch Med, Div Nucl Med, Abeno Ku, Osaka 5458585, Japan
关键词
D O I
10.1006/gyno.2000.6081
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The effectiveness of positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) for diagnosis of uterine sarcoma was evaluated in comparison to the effectiveness of magnetic resonance (MR) imaging and power Doppler imaging. Method. The cases of five Osaka City University Hospital patients diagnosed with uterine sarcoma based on histopathological examination, in whom FDG-PET, MR imaging, and power Doppler imaging studies had been performed preoperatively, were reviewed. A comparative study of the usefulness of these three imaging modalities for diagnosis of sarcoma was conducted. Tumors comprised three leiomyosarcomas, one endometrial stromal sarcoma, and one carcinosarcoma. Results. FDG-PET examinations were 100% positive for the five sarcomas; MR imagings were 80% positive (four of five cases), and US was 40% positive (two of five cases). The mean strandardized uptake value of the sarcomas was 4.5 +/- 1.3. Conclusion. The sarcoma lesions were clearly imaged by FDG-PET. FDG-PET may be a most useful diagnostic method for uterine sarcoma. (C) 2001 Academic Press.
引用
收藏
页码:372 / 377
页数:6
相关论文
共 16 条
[1]  
FUJII S, 1999, ATLAS MRI HISTOPATHO
[2]   Uterine sarcoma: Can it be differentiated from uterine leiomyoma with Doppler ultrasonography? A preliminary report [J].
Hata, K ;
Hata, T ;
Maruyama, R ;
Hirai, M .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 9 (02) :101-104
[3]   CANCER-DETECTION WITH WHOLE-BODY PET USING 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE [J].
HOH, CK ;
HAWKINS, RA ;
GLASPY, JA ;
DAHLBOM, M ;
TSE, NY ;
HOFFMAN, EJ ;
SCHIEPERS, C ;
CHOI, Y ;
REGE, S ;
NITZSCHE, E ;
MADDAHI, J ;
PHELPS, ME .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1993, 17 (04) :582-589
[4]  
HUBNER KF, 1993, GYNECOL ONCOL, V51, P192
[5]   UTERINE SARCOMA - A REPORT OF 10 CASES STUDIED BY TRANSVAGINAL COLOR AND PULSED DOPPLER SONOGRAPHY [J].
KURJAK, A ;
KUPESIC, S ;
SHALAN, H ;
JUKIC, S ;
KOSUTA, D ;
ILIJAS, M .
GYNECOLOGIC ONCOLOGY, 1995, 59 (03) :342-346
[6]  
Lamki LM, 1996, CANCER-AM CANCER SOC, V78, P2039, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2039::AID-CNCR1>3.0.CO
[7]  
2-J
[8]  
LANGEN KJ, 1993, J NUCL MED, V34, P355
[9]  
LAPELA M, 1994, J NUCL MED, V35, P1618
[10]  
PETERS WA, 1986, CANCER, V58, P2625, DOI 10.1002/1097-0142(19861215)58:12<2625::AID-CNCR2820581213>3.0.CO